Skip to main content
All lobbying filings

TIBER CREEK GROUP

Lobbying for ORGANON, LLC · Pharmaceutical Company.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 3
Health Issues

Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (PL 118-159)

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).

Budget/Appropriations

Issues related to women's health.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem